0.2000
0.0000
(0.00%)
At close: April 11 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 380.38k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| POUKALOV KONSTANTIN Director | Conversion of Exercise of derivative security at price 4.78 per share. | Direct | 173,514 | Feb 15, 2024 |
| GIANAKAKOS TOM ANASTASIOS Director | Conversion of Exercise of derivative security at price 2.52 per share. | Direct | 91,476 | Feb 15, 2024 |
| PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 4.78 per share. | Indirect | 173,514 | Feb 15, 2024 |
| STONE ADAM LEO Chief Executive Officer | Conversion of Exercise of derivative security at price 2.52 per share. | Direct | 91,476 | Feb 15, 2024 |
| SILBERMANN SUSAN MICHELE Director | Conversion of Exercise of derivative security at price 4.78 per share. | Direct | 173,514 | Feb 15, 2024 |
| GU EHONG Chief Financial Officer | Sale at price 0.17 per share. | Direct | 288 | Jan 2, 2024 |
Related Tickers
347850.KQ D&D Pharmatech
48,400.00
+7.44%
NBIO Nascent Biotech, Inc.
0.0023
-48.89%
6855.HK Ascentage Pharma Group International
37.050
+5.26%
HUMAW Humacyte, Inc.
0.4167
-0.79%
EPIX ESSA Pharma Inc.
1.5800
+3.95%
BVNRY Bavarian Nordic A/S
7.48
+5.50%
FBRX Forte Biosciences, Inc.
5.25
-10.87%
PRTC PureTech Health plc
16.16
+19.70%
SLRN Acelyrin, Inc.
2.2300
+3.72%
KZIA Kazia Therapeutics Limited
0.7700
+6.02%